2018, Cilt 48, Sayı 2, Sayfa(lar) 087-099 |
[ Türkçe Özet ]
[ PDF ]
[ Benzer Makaleler ]
|
New Antibacterials |
Ahmet Uğur AKBAL1, Ahmet Yılmaz ÇOBAN2, Belma DURUPINAR1 |
1Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Samsun 2Akdeniz Üniversitesi, Sağlık Bilimleri Bilimleri Fakültesi, Antalya |
Keywords: Antibacterial, antibiotic, new antibacterials |
The increase and spread of antibiotic resistance further
increase the risk of infections threatening the individual and
the society. New antibiotics active against infections and
resistant pathogens are needed. In recent years, new and
successful studies in development of new antibacterials have
been attracting attention. It has been observed that intensive
studies have been carried out in glycopeptides and
lipopeptides (oritavancin, telavancin, dalbavancin and
surotomycin), oxazolidinones (tedizolid, radezolide,
cadazolide and MRX-I), macrolides/ketolides (modithromycin
and solitromycin), aminoglycosides (plasomycin), quinolones
(nemonoxacin, delafloxacin and avarofloxacin), tetracyclines
(omadacycline and eravacycline). In this review, the
developments in antibacterials in recent years have been
reviewed.
|
[ Türkçe Özet ]
[ PDF ]
[ Benzer Makaleler ]
|